| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2006/061680WO2006111549A1 (de) | 2005-04-21 | 2006-04-19 | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen |
| DE102005019201ADE102005019201A1 (de) | 2006-04-19 | 2006-04-19 | Neue Verbindungen zur Behandlung von entzündlichen Erkrankungen |
| Publication Number | Publication Date |
|---|---|
| DK1874781T3true DK1874781T3 (da) | 2009-11-02 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK06743350TDK1874781T3 (da) | 2006-04-19 | 2006-04-19 | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme |
| Country | Link |
|---|---|
| US (3) | US7511045B2 (da) |
| EP (2) | EP2060575A1 (da) |
| JP (1) | JP5021624B2 (da) |
| KR (1) | KR101335964B1 (da) |
| CN (1) | CN101163706A (da) |
| AR (1) | AR053235A1 (da) |
| AT (1) | ATE434620T1 (da) |
| AU (1) | AU2006237354B2 (da) |
| BR (1) | BRPI0608387A2 (da) |
| CA (1) | CA2605161A1 (da) |
| CY (1) | CY1109348T1 (da) |
| DE (2) | DE102005019201A1 (da) |
| DK (1) | DK1874781T3 (da) |
| EA (1) | EA013108B1 (da) |
| ES (1) | ES2328400T3 (da) |
| HR (1) | HRP20090395T1 (da) |
| IL (1) | IL186749A (da) |
| MX (1) | MX2007012313A (da) |
| NO (1) | NO20074615L (da) |
| NZ (1) | NZ563488A (da) |
| PL (1) | PL1874781T3 (da) |
| PT (1) | PT1874781E (da) |
| RS (1) | RS51163B (da) |
| SI (1) | SI1874781T1 (da) |
| TW (1) | TWI380984B (da) |
| UA (1) | UA93872C2 (da) |
| WO (1) | WO2006111549A1 (da) |
| ZA (1) | ZA200707591B (da) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101335964B1 (ko) | 2005-04-21 | 2013-12-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 염증성 질환 치료용 디하이드로티에노피리미딘 |
| US8927546B2 (en)* | 2006-02-28 | 2015-01-06 | Dart Neuroscience (Cayman) Ltd. | Therapeutic piperazines |
| US7829713B2 (en)* | 2006-02-28 | 2010-11-09 | Helicon Therapeutics, Inc. | Therapeutic piperazines |
| EP1847543A1 (de)* | 2006-04-19 | 2007-10-24 | Boehringer Ingelheim Pharma GmbH & Co. KG | Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen |
| PL2205608T3 (pl)* | 2007-10-18 | 2013-09-30 | Boehringer Ingelheim Int | Sposób otrzymywania dihydrotieno[3,2-d]pirymidyn i związków pośrednich stosowanych w tym sposobie |
| WO2009053268A1 (de)* | 2007-10-19 | 2009-04-30 | Boehringer Ingelheim International Gmbh | Neue phenyl-substituierte piperazino-dihydrothienopyrimidine |
| ATE537175T1 (de) | 2007-10-19 | 2011-12-15 | Boehringer Ingelheim Int | Neue piperazino-dihydrothienopyrimidin-derivate |
| KR20100075930A (ko)* | 2007-10-19 | 2010-07-05 | 베링거 인겔하임 인터내셔날 게엠베하 | 헤테로사이클-치환된 피페라지노-디하이드로티에노피리미딘 |
| DK2610258T3 (da)* | 2007-10-19 | 2014-11-10 | Boehringer Ingelheim Int | Substituerede piperidindihydrothienopyrimidiner |
| WO2009080533A1 (en) | 2007-12-21 | 2009-07-02 | F. Hoffmann-La Roche Ag | Heteroaryl derivatives as orexin receptor antagonists |
| AU2009203773B2 (en) | 2008-01-11 | 2013-04-18 | F. Hoffmann-La Roche Ag | Modulators for amyloid beta |
| KR101247840B1 (ko) | 2008-02-22 | 2013-03-26 | 에프. 호프만-라 로슈 아게 | 아밀로이드 베타 조절제 |
| EA019735B1 (ru)* | 2008-05-13 | 2014-05-30 | Бёрингер Ингельхайм Интернациональ Гмбх | СИНТЕЗ ДИГИДРОТИЕНО[3,2-d]ПИРИМИДИНДИОЛОВ И СХОДНЫХ ПИРИМИДИНДИОЛОВ |
| EP2334665B1 (en) | 2008-10-09 | 2013-07-10 | F. Hoffmann-La Roche AG | Modulators for amyloid beta |
| KR101293421B1 (ko) | 2008-11-10 | 2013-08-05 | 에프. 호프만-라 로슈 아게 | 헤테로사이클릭 감마 분비효소 조절제 |
| EP2373625B1 (en) | 2008-12-24 | 2014-10-08 | Syngenta Limited | Methods for the preparation of aryl amides |
| WO2010097332A1 (de)* | 2009-02-27 | 2010-09-02 | Boehringer Ingelheim International Gmbh | Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids |
| JP2012519160A (ja)* | 2009-02-27 | 2012-08-23 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｐｄｅ４阻害剤及びｎｓａｉｄを含有する組み合わせ薬 |
| JP5746631B2 (ja)* | 2009-03-10 | 2015-07-08 | 武田薬品工業株式会社 | ベンゾフラン誘導体 |
| US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
| EP2721036B1 (en)* | 2011-06-15 | 2015-07-22 | Takeda GmbH | Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds |
| WO2013019966A1 (en)* | 2011-08-04 | 2013-02-07 | Allergan, Inc. | Aromatic bycyclic derivatives as cxcr4 receptor modulators |
| US9206195B2 (en)* | 2011-08-09 | 2015-12-08 | Boehringer Ingelheim International Gmbh | Dihydrothienopyrimidines |
| US20130059866A1 (en) | 2011-08-24 | 2013-03-07 | Boehringer Ingelheim International Gmbh | Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma |
| US9802954B2 (en) | 2011-08-24 | 2017-10-31 | Boehringer Ingelheim International Gmbh | Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma |
| GB201203266D0 (en)* | 2012-02-24 | 2012-04-11 | Randox Lab Ltd | Assay for the detection of the phenylpiperazine family |
| WO2014105958A2 (en) | 2012-12-26 | 2014-07-03 | Medivation Technologies, Inc. | Fused pyrimidine compounds and use thereof |
| JP6307524B2 (ja) | 2013-02-04 | 2018-04-04 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | Ｐｄｅ４阻害薬としての、４−アミノ置換縮合ピリミジン化合物 |
| WO2014124860A1 (en) | 2013-02-14 | 2014-08-21 | Boehringer Ingelheim International Gmbh | Specific pde4b-inhibitors for the treatment of diabetes mellitus |
| KR102232221B1 (ko) | 2013-03-14 | 2021-03-26 | 다트 뉴로사이언스 (케이만) 엘티디. | Pde4 억제제로서 치환된 피리딘 및 피라진 화합물 |
| CN104140426B (zh)* | 2013-05-07 | 2017-02-01 | 上海汇伦生命科技有限公司 | 嘧啶并咪唑类化合物、其药物组合物及其制备方法和用途 |
| CN103893183B (zh)* | 2014-03-12 | 2016-02-10 | 中山大学 | 1-（2-氯苯基）-4-{噻吩并[3,2-d]嘧啶-4-基}哌嗪化合物在制备抗HIV-1病毒药物中应用 |
| AU2015357596A1 (en)* | 2014-12-05 | 2017-06-29 | Southern Research Institute | Heterocyclic compounds as biogenic amine transport modulators |
| WO2019045824A1 (en)* | 2017-09-01 | 2019-03-07 | Kadmon Corporation, Llc | ALPHA PROPELLER PROTEIN KINASE INHIBITORS ("COILED-COIL") ASSOCIATED WITH RHO |
| CN111108109A (zh) | 2017-09-20 | 2020-05-05 | 利奥制药有限公司 | 取代的二氢噻吩并嘧啶及其作为磷酸二酯酶抑制剂的用途 |
| FI3700529T3 (fi) | 2017-10-23 | 2025-09-18 | Boehringer Ingelheim Int | Uusi aktiivisten aineiden yhdistelmä etenevien fibrotisoivien interstitiaalisten keuhkosairauksien (pf-ild) hoitoon |
| EP3724196B9 (en) | 2017-12-15 | 2023-03-22 | UNION therapeutics A/S | Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors |
| EP3724194B1 (en) | 2017-12-15 | 2023-12-27 | UNION therapeutics A/S | Substituted azetidine dihydrothienopyrimidines and their use as phosphodiesterase inhibitors |
| JP7201688B2 (ja) | 2017-12-15 | 2023-01-10 | ユニオン・セラピューティクス・アクティエセルスカブ | 置換テトラヒドロピランジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用 |
| CN111285882B (zh)* | 2018-12-07 | 2022-12-02 | 四川科伦博泰生物医药股份有限公司 | 稠环化合物、包含其的药物组合物及其制备方法和用途 |
| CN113248518B (zh)* | 2021-06-21 | 2022-03-25 | 山东大学 | 嘧啶哌嗪类衍生物及其制备方法与应用 |
| WO2023104958A1 (en) | 2021-12-09 | 2023-06-15 | Boehringer Ingelheim International Gmbh | New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases |
| JP2024541514A (ja) | 2021-12-09 | 2024-11-08 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 進行性線維化を伴う間質性肺疾患を処置するための、新たな治療的組合せ |
| CN119630673A (zh)* | 2022-08-09 | 2025-03-14 | 西藏海思科制药有限公司 | Pde4b抑制剂及其用途 |
| CN119947728A (zh) | 2022-09-28 | 2025-05-06 | 勃林格殷格翰国际有限公司 | 生物标志物在用pde4b抑制剂治疗纤维化病症中的用途 |
| WO2024067660A1 (zh) | 2022-09-29 | 2024-04-04 | 苏州爱科百发生物医药技术有限公司 | 氮杂稠环类化合物、其制备方法及其在医药上的应用 |
| CN115887463A (zh)* | 2022-12-27 | 2023-04-04 | 瑞石生物医药有限公司 | 一种含环酰胺化合物的药物组合物 |
| CN116925099B (zh)* | 2023-07-21 | 2025-06-03 | 厦门大学 | 手性二氢噻吩并嘧啶亚砜的制备方法及其应用与其2、4位取代化合物 |
| WO2025067168A1 (zh)* | 2023-09-25 | 2025-04-03 | 苏州爱科百发生物医药技术有限公司 | 氮杂稠环类化合物及其制备方法和用途 |
| CN120398908A (zh)* | 2024-02-01 | 2025-08-01 | 艾派克斯生物科技有限公司 | Pde4b抑制剂及其药物组合物和用途 |
| WO2025162431A1 (zh)* | 2024-02-04 | 2025-08-07 | 西藏海思科制药有限公司 | 一种pde4b抑制剂化合物的口服药物组合物及其制备方法 |
| WO2025162289A2 (zh)* | 2024-02-04 | 2025-08-07 | 西藏海思科制药有限公司 | 一种pde4b抑制剂的晶型及其在医药上的用途 |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1470336A1 (de) | 1962-07-04 | 1969-03-20 | Thomae Gmbh Dr K | Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung |
| NL122810C (da)* | 1963-06-17 | |||
| DE1470356A1 (de)* | 1964-01-15 | 1970-04-30 | Thomae Gmbh Dr K | Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
| NL123139C (da) | 1965-03-31 | |||
| BE754606A (fr)* | 1969-08-08 | 1971-02-08 | Thomae Gmbh Dr K | Nouvelles 2-aminoalcoylamino-thieno(3,2-d)pyrimidines et leurs procedesde fabrication |
| DE1940572A1 (de)* | 1969-08-08 | 1971-02-11 | Thomae Gmbh Dr K | Neue 2-Aminoalkylamino-thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung |
| DE2032687A1 (en)* | 1970-07-02 | 1972-01-05 | Dr. Karl Thomae Gmbh, 7950 Biberach | Cardiovascular 2-aminoalkylamino-thienopyrimidines - and 4-morpholino derivatives from 4-diethanolamino-compounds by intramolecular cyclisa |
| US3763156A (en)* | 1970-01-28 | 1973-10-02 | Boehringer Sohn Ingelheim | 2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines |
| FR2082496A5 (da) | 1970-03-18 | 1971-12-10 | Westinghouse Freins & Signaux | |
| DE2121950A1 (en)* | 1971-05-04 | 1972-11-23 | Dr. Karl Thomae Gmbh, 7950 Biberach | Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity |
| RO62428A (fr)* | 1971-05-04 | 1978-01-15 | Thomae Gmbh Dr K | Procede pour la preparation des thyeno-(3,2-d)-pyrimidines |
| DE2750288A1 (de)* | 1977-11-10 | 1979-05-17 | Thomae Gmbh Dr K | Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel |
| US4256737A (en) | 1979-06-11 | 1981-03-17 | Syntex (U.S.A.) Inc. | Long acting depot injectable formulations for LH-RH analogues |
| US4265738A (en)* | 1979-10-25 | 1981-05-05 | Goncharov Evgeny S | Cleaning and/or grading machine for free-flowing materials |
| US5187168A (en)* | 1991-10-24 | 1993-02-16 | American Home Products Corporation | Substituted quinazolines as angiotensin II antagonists |
| JPH07330777A (ja)* | 1994-06-08 | 1995-12-19 | Taisho Pharmaceut Co Ltd | チエノ［３，２−ｄ］ピリミジン−４−オン誘導体 |
| US6339089B2 (en)* | 1997-08-13 | 2002-01-15 | Fujirebio Inc. | Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same |
| HRP20030276B1 (en) | 2000-10-12 | 2006-02-28 | Boehringer Ingelheim Pharma Gmbh & Co. Kg. | Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament |
| DE10064994A1 (de)* | 2000-12-23 | 2002-07-04 | Merck Patent Gmbh | Sulfamidothienopyrimidine |
| WO2003000265A1 (de) | 2001-06-22 | 2003-01-03 | Boehringer Ingelheim Pharma Gmbh & Co.Kg | Kristallines anticholinergikum, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels |
| US6587548B2 (en) | 2001-07-17 | 2003-07-01 | Hewlett-Packard Development Co., L.P. | Method and system of using a single telephone number for multiple services |
| WO2003055890A1 (en)* | 2001-12-21 | 2003-07-10 | Bayer Pharmaceuticals Corporation | Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents |
| ES2305435T3 (es)* | 2002-01-10 | 2008-11-01 | Bayer Healthcare Ag | Inhibidores de la rho-quinasa. |
| WO2004096810A1 (en)* | 2003-04-29 | 2004-11-11 | Pfizer Limited | 5,7-diaminopyrazolo`4,3-d!pyrimidines useful in the treatment of hypertension |
| MY141220A (en)* | 2003-11-17 | 2010-03-31 | Astrazeneca Ab | Pyrazole derivatives as inhibitors of receptor tyrosine kinases |
| WO2005082865A1 (ja)* | 2004-02-27 | 2005-09-09 | Astellas Pharma Inc. | 縮合二環性ピリミジン誘導体 |
| KR101335964B1 (ko) | 2005-04-21 | 2013-12-04 | 베링거 인겔하임 인터내셔날 게엠베하 | 염증성 질환 치료용 디하이드로티에노피리미딘 |
| Publication | Publication Date | Title |
|---|---|---|
| DK1874781T3 (da) | Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme | |
| DK2056807T3 (da) | Behandling af inflammatoriske sygdomme | |
| DK2474321T3 (da) | Sammensætninger til behandling af collagenmedierede sygdomme | |
| DK3456707T3 (da) | 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme | |
| DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
| DK2478907T3 (da) | Sammensætninger til behandling af kræft | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| PL3354276T3 (pl) | Kompozycje do leczenia zapalenia przewodu pokarmowego | |
| DK2056842T3 (da) | Modificeret galactosylceramid til behandling af cancerøse sygdomme | |
| ES1063346Y (es) | Andador | |
| SMAP200900085A (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative | |
| DK2285808T3 (da) | Spiroindolderivater til behandling af parasitsygdomme | |
| DK2445912T3 (da) | Ny forbindelse anvendelig til behandlingen af degenerative og inflammatoriske sygdomme | |
| DK1948615T3 (da) | Til behandling af gynækologiske sygdomme egnede pyrazolderivater | |
| DK2004204T3 (da) | Behandling af neurodegenerative sygdomme med selenat | |
| DK2035369T3 (da) | Terapeutiske | |
| DK2099446T3 (da) | Fremgangsmåde til behandling af inflammatorisk tarmsygdom | |
| DK2209784T3 (da) | Forbindelser til behandling af hepatitis C | |
| DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
| DK2107870T3 (da) | Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom | |
| DK1896077T3 (da) | Fremgangsmåder og sammensætninger til forebyggelse og behandling af inflammatoriske sygdomme | |
| PL2205720T3 (pl) | Kompozycja do leczenia stwardnienia rozsianego | |
| DK2022504T3 (da) | Salve til behandling af hæmorider | |
| DK2012814T3 (da) | Fremgangsmåder til behandling af autoimmunsygdomme | |
| DK2296651T3 (da) | 5-hydroxymethyl-oxazolidin-2-on-derivater til behandling af bakterielle intestinale sygdomme |